GF-TRIPLE 50mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.

For research use only — not for human or veterinary use.

Product Overview

GF-TRIPLE is a synthetic research peptide studied in controlled laboratory environments for its involvement in multi-receptor metabolic pathway modelling and coordinated endocrine signalling analysis. This lyophilized 50 mg preparation is supplied in a sealed research vial and supports reproducible in vitro experimentation.

Peptide Overview

GF-TRIPLE belongs to a class of advanced receptor-active peptides incorporated into laboratory research examining complex metabolic communication systems and dual-pathway interaction dynamics. Its defined molecular structure and reproducible chromatographic profile make it suitable for comparative biochemical evaluation under controlled experimental conditions.

Scientific Context

Research into multi-pathway metabolic peptides expanded significantly during the 2010s as laboratories explored integrated signalling systems governing energy regulation and biochemical cascade coordination. GF-TRIPLE is utilised within this framework to investigate receptor-binding behaviour, intracellular pathway interaction and coordinated signalling modulation.

Mechanistic Focus in Research

• Multi-receptor metabolic pathway modelling
• Integrated endocrine signalling analysis
• Receptor-binding and activation dynamics
• Comparative structure–function evaluation
• Controlled in vitro metabolic research studies

Analytical Verification (COA)

Independent Liquilabs analysis confirms validation for Batch GF-TRIPLE50-B241. Key analytical results include:

• Assay Content: 52.43 mg (± 0.26)
• Identification – Retention Time: 1.00
• Identification – Spectrum: 1000
• Purity: greater than 99.8 percent
• Bioburden: not detected
• Endotoxins: less than 0.001 EU per mg
• Heavy Metals: not detected including arsenic, cadmium, cobalt, lead, nickel, mercury and vanadium

All analytical values were obtained using validated chromatographic, spectroscopic and microbiological procedures. Results relate only to the tested batch sample.

Research Applications

• Advanced metabolic pathway modelling
• Multi-receptor signalling research
• Biochemical cascade interaction analysis
• Comparative metabolic peptide evaluation
• Controlled laboratory investigations

Grail Formula Quality

Every Grail Formula research peptide undergoes independent third-party laboratory testing for identity, assay accuracy, purity and microbial safety. Each batch is verified for analytical consistency and reproducibility to support reliable scientific research outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptide materials with batch-number traceability and sealed-vial integrity. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment
• Supplied for human investigational use

Independently verified by Liquilabs s.r.o. (Czechia)
Validated assay content 52.43 mg
Purity greater than 99.8 percent
Retention time and spectral identity confirmation
Endotoxin levels below 0.001 EU per mg
No detectable microbial contamination
No detectable heavy metals
EU shipments include bacteriostatic water
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.